Skip to main content
US EQUITIES OPEN CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
CR

CRBUStock

Nasdaq Global Select Market · Healthcare · US

$0.3137 last close 2026-11-18
Open in terminalCompare
Price alert

Verdicts genuinely change. Free email alert the moment CRBU's does — no target price to set, unlike a price alert.

Stable Ratio screen, 1 of 7 decided standards passing. No standard's deciding ratio sits within 3 points of its line. What would change it

Sharia status
NOT COMPLIANT
Per our in-house ratio engine
1 of 7 pass our financial screen — the standards disagree
Purification 100.00% *HTR non-permissible income <0.01%
🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
No trade setup shown — a stock that isn't cleanly Sharia-compliant never gets a bullish verdict here.

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure2 of 5 timeframes bullish · 87.0% aligned
VWAPPrice below VWAP ($0.35)
VolumeRelative volume 4.3× the 20-day average
Momentum10-day rate of change -29.4%

CRBU is currently considered not halal (non-compliant), per our in-house ratio engine. See the full ratio breakdown and business-activity screen below for the reasoning.

⚠️ Financial ratios are only half the screen. A company whose core business is in an excluded sector — weapons/defense, alcohol, gambling, conventional (interest-based) finance, tobacco, pork, or adult entertainment — is non-compliant even if every debt and income ratio passes. So passing ratios below don't override this verdict; check the business-activity screen for the reason.

434 other Healthcare stocks pass this same screen. See compliant Healthcare stocks →

Market & analysts
Wall Street consensus
BUY
12 analysts · worsening
Price target
$5.00
+1493.9% · 3 analysts
Institutional own.
48.0%
of shares
Momentum (10d)
-29.4%
rate of change
SMC grade
D · 47
87.0% aligned
100.00% *
Purification ratio (secondary provider, uncertain)
<0.01%
Non-permissible income — HTR, from filings (2026-09-30)
D · 47
SMC grade — 87.0% timeframe alignment
-29.4%
Rate of change (10d)
BUY ↘
Wall Street consensus (12) — worsening
$5.00
Price target (+1493.9%) · 3 analysts
48.0%
Institutional ownership

How the status reached this point

Non-compliant · status tracked since Nov 17, 2026

No change to CRBU’s published status has been recorded since our daily status check began on Nov 17, 2026. What it read before then is not on record here.

Read once a day from our own screen, last on Nov 17, 2026. The per-methodology record is under “What changed, and when” in the in-house research.

Free email, sent when our compliance re-scan finds a change.

🕌 In-house Compliance Research

Computed from published company financials, balance sheet as of 2026-09-30. These ratios come from the issuer's own published statements rather than structured SEC data.

AAOIFI divides by the market cap: $38.1M as of 2026-11-17.

Business activity: cleared (no excluded categories detected)

AAOIFI Fail 1 of 3 ratios pass
RatioValueThresholdResult
Interest-bearing debt 69.10% 30.00% Fail(39.1pp over)
Interest-bearing investments 248.72% 30.00% Fail(218.7pp over)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
Usmani Fail 3 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 21.41% 33.00% Pass(11.6pp buffer)
Interest-bearing investments 77.06% 33.00% Fail(44.1pp over)
Non-liquid assets 22.52% at least 20.00% Pass(2.5pp above the floor)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
MSCI Fail 2 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 21.41% 33.33% Pass(11.9pp buffer)
Cash + interest-bearing securities 77.06% 33.33% Fail(43.7pp over)
Accounts receivable 77.48% 33.33% Fail(44.1pp over)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
FTSE Fail 2 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 0.00% 33.33% Pass(33.3pp buffer)
Cash + interest-bearing securities 77.06% 33.33% Fail(43.7pp over)
Accounts receivable 77.48% 50.00% Fail(27.5pp over)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
Dow Jones Islamic Market Fail 3 of 4 ratios pass

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 14.10% 33.00% Pass(18.9pp buffer)
Cash + interest-bearing securities 50.74% 33.00% Fail(17.7pp over)
Accounts receivable 0.28% 33.00% Pass(32.7pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
S&P Shariah Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 10.24% 33.00% Pass(22.8pp buffer)
Cash + interest-bearing securities 36.87% 49.00% Pass(12.1pp buffer)
Accounts receivable 0.20% 49.00% Pass(48.8pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
MSCI M-Series Fail 3 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 10.24% 33.33% Pass(23.1pp buffer)
Cash + interest-bearing securities 36.87% 33.33% Fail(3.5pp over)
Accounts receivable 37.07% 49.00% Pass(11.9pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

How close is it to flipping?

Every current reading against its own line, closest first. A verdict is only as durable as that distance.

Usmani (% of total assets)nonliquid assets ratio · floor 2.5pts
AAOIFI Standard 21 (% of market cap)non permissible income ratio 5.0pts
Usmani (% of total assets)non permissible income ratio 5.0pts
AAOIFI Standard 21 (% of market cap)investments ratio 218.7pts
MSCI Islamic Index (% of total assets)receivables ratio 44.1pts
Usmani (% of total assets)investments ratio 44.1pts

The numbers the ratios are built from

Read from CRBU's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.

LineFigureAs reportedRead from
RevenueTotal revenue for the period $11.2M 2026-09-30 RevenueFromContractWithCustomerExcludingAssessedTax
Interest-bearing debtShort and long-term borrowings $0 2026-09-30 no debt tag reported in 3+ years (treated as $0)
Cash and interest-bearing securitiesCash, equivalents and marketable securities $94.8M 2026-09-30 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents, AvailableForSaleSecuritiesDebtSecuritiesCurrent
Total assetsBalance sheet total $123.0M 2026-09-30 Assets
Market capDenominator for AAOIFI $38.1M live quote price x shares
36-month average market capDenominator for S&P Shariah and MSCI M-Series $215.4M 756 trading days closes x shares
24-month average market capDenominator for Dow Jones Islamic Market $152.6M 504 trading days closes x shares
Non-permissible revenueInterest and excluded income $0 2026-09-30 no interest-income tag reported in 3+ years (treated as $0)

Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.

Sources

Filing information. Balance sheet as of 2026-09-30. Income statement as of 2026-09-30. Screened 2026-11-17.

Filing links appear after the next screen: this row was screened before filing citations were recorded.

  • Total assets$123.0M
    Assets · balance sheet as of 2026-09-30
  • Interest-bearing debt$0
    no debt tag reported in 3+ years (treated as $0) · balance sheet as of 2026-09-30
  • Cash and interest-bearing securities$94.8M
    CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents, AvailableForSaleSecuritiesDebtSecuritiesCurrent · balance sheet as of 2026-09-30
  • Receivables$518.0K
    AccountsReceivableNetCurrent · balance sheet as of 2026-09-30
  • Revenue$11.2M
    RevenueFromContractWithCustomerExcludingAssessedTax · income statement as of 2026-09-30
  • Interest income (non-permissible)$0
    no interest-income tag reported in 3+ years (treated as $0) · income statement as of 2026-09-30
  • Market cap$38.1M
    Market-data quote at screen time, 2026-11-17 · not a filing figure, so no link

What changed, and when

Verdict history for CRBU. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.

  • 2026-11-17 Unverified → Pass filing re-screen
  • 2026-11-17 Unverified → Fail filing re-screen

Tracked since 2026-09-07.

What would change the status

The headline verdict is the majority of the decided ratio standards — 1 pass and 6 fail of 7 — with a business-activity screen and any hold applied on top. Balance sheet as of 2026-09-30; market cap as stored on 2026-11-17.

No standard's deciding ratio sits within 3 points of its line.

The ratios that move with the share price

AAOIFI's debt ratio is $26.3M debt (operating leases included, as the screen counts it) over a market cap of $38.1M (as of 2026-11-17), 69.1% against a 30% line.

It would pass if the market cap rose above $87.8M (+130%), about $0.81 a share against $0.35 implied by the screen's own figures.

AAOIFI would then fail; the majority verdict would stay Not compliant (1 of 7 decided standards passing).

AAOIFI's investments ratio is $94.8M cash and interest-bearing investments over a market cap of $38.1M (as of 2026-11-17), 248.7% against a 30% line.

It would pass if the market cap rose above $316.0M (+729%), about $2.92 a share against $0.35 implied by the screen's own figures.

AAOIFI would then pass; the majority verdict would stay Not compliant (2 of 7 decided standards passing).

At the screen's market cap, it would take $83.4M less cash and interest-bearing investments to clear the line.

AAOIFI would then fail, and the majority verdict would move from Not compliant to Compliant (6 of 7 decided standards passing, counting every standard that divides the same figure).

Only AAOIFI divides by the market cap itself. The Dow Jones, S&P and MSCI M-Series standards divide by a 24- or 36-month average and the others by total assets, so a day's price move does not reach them. Figures are the screen's own; the live market cap differs from the stored one.

Shariah-compliant alternatives

Compliant companies in Biotechnology listed on the same market, largest first. Each is screened on its own; none carries a documented concern or a hold.

CompanyMarket capPrice, day
VRTXVertex Pharmaceuticals, Inc. $121.1B —
REGNRegeneron Pharmaceuticals, Inc. $85.3B —
ARGXArgen X SE - ADR $64.3B —
ONCBeOne Medicines Ltd. American Depositary Shares $40.4B —
ALNYAlnylam Pharmaceuticals Inc $31.6B —

A dash means no fresh quote is cached for that symbol; this list does not fetch one.

Funds that hold CRBU

2 of the 193 funds whose filed holdings we currently hold own CRBU shares. That set is a fixed list of widely held index funds and Shariah funds, plus the funds our look-through has read most recently. It is not every fund that owns CRBU.

You may already own it

Widely held U.S. index funds. If you own one, you own CRBU through it. None of them is a Shariah fund; the last column is our look-through of each.

FundCRBU in fundFund compliant by weight
SCHB Schwab U.S. Broad Market ETF 0.00% 53%
VTI VANGUARD TOTAL STOCK MARKET INDEX FUND 0.00% 54%

Sorted by CRBU’s share of each fund, from the fund’s latest SEC N-PORT filing. “Compliant by weight” is the share of the fund’s holdings our look-through screens compliant. A fund is listed only where its filing is mostly equity and names CRBU once, so a bond is not counted as the shares. Shariah funds are those with a recorded certification, on our halal ETF list, or named Shariah, Islamic, Halal or Sukuk.

Tracked investors holding CRBU
InvestorFirmPositionWeightAs of
Peter Brown Renaissance Technologies $3M 0.0% 2026-09-30
Lee Ainslie Maverick Capital $1M 0.0% 2026-09-30
Robert Bruce Bruce & Co. $0M 0.1% 2026-09-30
Ken Griffin Citadel Advisors $0M 0.0% 2026-09-30

From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.

2.431.901.370.850.322025-11-182026-05-212026-11-18

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
0.30
S2
0.31
S1
0.33
PIVOT
0.34
R1
0.35
R2
0.37
R3
0.38

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
0.2173 – 0.4101
±30.74% from 0.3137, made 2026-11-18 · resolves 2026-11-25
STRONG SELL
from 19 indicators
77.1% of our last 20463 forecasts — across every instrument we forecast, not just this one — landed inside their stated range, and 50.1% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

STRONG SELL
19 indicators
OscillatorsSTRONG BUY
5 buy · 0 neutral · 2 sell
Moving averagesSTRONG SELL
0 buy · 0 neutral · 12 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)22.80BUY
Stochastic %K (14)4.63BUY
CCI (20)-149.83BUY
Williams %R (14)-95.37BUY
MACD (12,26,9)0.02BUY
ROC (10)-28.27SELL
Momentum (10)-0.13SELL
EMA (10)0.38SELL
SMA (10)0.38SELL
EMA (20)0.45SELL
SMA (20)0.43SELL
EMA (30)0.54SELL
SMA (30)0.45SELL
EMA (50)0.72SELL
SMA (50)0.76SELL
EMA (100)1.05SELL
SMA (100)1.21SELL
EMA (200)1.36SELL
SMA (200)1.56SELL

About CRBU

Healthcare · Biotechnology

Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It offers a genome-editing platform based on novel CRISPR hybrid RNA-DNA genome-editing technology that enables precise genome editing of allogeneic cell therapies. The company develops Vispacabtagene Regedleucel, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.

cariboubio.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Grade verdict

Weak — low conviction, small size or skip

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily BEARISH 43
⏰ 4H BEARISH 41
🕐 1H BEARISH 98
⏱ 15-Min BULLISH 130
⏲ 5-Min BULLISH 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

-29.4%
Rate of change (10d)
4.3×
Volume vs its 20-day average
-0.13
MACD (no fresh cross)
$0.32
Volume POC (today)
$0.31 – $0.32
Value area

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is this a fatwa?

No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.

Why can the standards disagree?

Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.

How often is this re-screened?

Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.

Do I need to purify dividends?

If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-11-10 · Asset managers net 914130 (-14454)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.